Molecular Mechanisms Driving and Regulating the AAA+ ATPase VCP/p97, an Important Therapeutic Target for Treating Cancer, Neurological and Infectious Diseases
Citations Over TimeTop 13% of 2023 papers
Abstract
p97/VCP, a highly conserved type II ATPase associated with diverse cellular activities (AAA+ ATPase), is an important therapeutic target in the treatment of neurodegenerative diseases and cancer. p97 performs a variety of functions in the cell and facilitates virus replication. It is a mechanochemical enzyme that generates mechanical force from ATP-binding and hydrolysis to perform several functions, including unfolding of protein substrates. Several dozens of cofactors/adaptors interact with p97 and define the multifunctionality of p97. This review presents the current understanding of the molecular mechanism of p97 during the ATPase cycle and its regulation by cofactors and small-molecule inhibitors. We compare detailed structural information obtained in different nucleotide states in the presence and absence of substrates and inhibitors. We also review how pathogenic gain-of-function mutations modify the conformational changes of p97 during the ATPase cycle. Overall, the review highlights how the mechanistic knowledge of p97 helps in designing pathway-specific modulators and inhibitors.
Related Papers
- → Bacterial Hsp90 ATPase Assays(2017)2 cited
- → The effect of inorganic pyrophosphate on the activity and Pi‐binding properties of mitochondrial F1‐ATPase(1988)31 cited
- → Complex cooperativity of ATP hydrolysis in the F1-ATPase molecular motor(2003)10 cited
- → Rotary-angle dependency of ATP-binding affinity of F1-ATPase(2004)
- → Complex cooperativity of ATP hydrolysis in the F1-ATPase molecular motor(2004)